Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Aisner

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Cancer Journal (Sudbury, Mass.)|August 2, 2005
Targeting COX-2/PG-E2 with a COX-2 inhibitor in combination with chemotherapy for non-small cell lung cancer: are we ready for phase III?Joseph Aisner
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 1, 2007
Overview of the changing paradigm in cancer treatment: oral chemotherapyJoseph Aisner
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
CT screening for lung cancer: are we ready for wide-scale application?Joseph Aisner
Seminars in Oncology|May 23, 2002
Pemetrexed for diffuse malignant pleural mesotheliomaChristian Manegold, Joseph Aisner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Changing face of small-cell lung cancer: real and artifactDavid S Ettinger, Joseph Aisner
Translational Lung Cancer Research|November 9, 2017
Erratum to current state of immunotherapy for non-small cell lung cancerJyoti Malhotra, Salma K Jabbour, Joseph Aisner
Translational Lung Cancer Research|May 23, 2017
Current state of immunotherapy for non-small cell lung cancerJyoti Malhotra, Salma K Jabbour, Joseph Aisner
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 1, 2007
Current issues associated with oral chemotherapy: a roundtable discussionSusan Goodin, Joseph Aisner, Sylvia B Bartel, et al.
Journal of Thoracic Disease|December 7, 2020
Local treatment of synchronous oligometastatic non-small cell lung cancer (NSCLC)-current consensus and future perspectivesDoaa Said Almeldin, Jyoti Malhotra, Malini Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Sequencing topotecan and etoposide plus cisplatin to overcome topoisomerase I and II resistance: a pharmacodynamically based Phase I trialJoseph Aisner, Rita Musanti, Stephanie Beers, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Cancer Journal (Sudbury, Mass.)|August 2, 2005
Targeting COX-2/PG-E2 with a COX-2 inhibitor in combination with chemotherapy for non-small cell lung cancer: are we ready for phase III?Joseph Aisner
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 1, 2007
Overview of the changing paradigm in cancer treatment: oral chemotherapyJoseph Aisner
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
CT screening for lung cancer: are we ready for wide-scale application?Joseph Aisner
Seminars in Oncology|May 23, 2002
Pemetrexed for diffuse malignant pleural mesotheliomaChristian Manegold, Joseph Aisner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Changing face of small-cell lung cancer: real and artifactDavid S Ettinger, Joseph Aisner
Translational Lung Cancer Research|November 9, 2017
Erratum to current state of immunotherapy for non-small cell lung cancerJyoti Malhotra, Salma K Jabbour, Joseph Aisner
Translational Lung Cancer Research|May 23, 2017
Current state of immunotherapy for non-small cell lung cancerJyoti Malhotra, Salma K Jabbour, Joseph Aisner
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 1, 2007
Current issues associated with oral chemotherapy: a roundtable discussionSusan Goodin, Joseph Aisner, Sylvia B Bartel, et al.
Journal of Thoracic Disease|December 7, 2020
Local treatment of synchronous oligometastatic non-small cell lung cancer (NSCLC)-current consensus and future perspectivesDoaa Said Almeldin, Jyoti Malhotra, Malini Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Sequencing topotecan and etoposide plus cisplatin to overcome topoisomerase I and II resistance: a pharmacodynamically based Phase I trialJoseph Aisner, Rita Musanti, Stephanie Beers, et al.
Pageof 7